Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.

Spotlight

03.18.15 Allena Pharmaceuticals Announces Positive Phase 2a Data of ALLN-177 for the Treatment of Hyperoxaluria

01.08.15 Allena Pharmaceuticals to Present at 2015 J.P. Morgan Healthcare Conference